Metabolites
Displaying compounds 1626 - 1650 of 16042 in total
YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
---|---|---|---|---|
YMDB12333 | CDP-DG(16:0/26:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(hexacosanoyloxy)-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H101N3O15P2 1094.356 | |
YMDB12334 | CDP-DG(16:0/26:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(12Z)-hexacos-12-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C54H99N3O15P2 1092.34 | |
YMDB12335 | CDP-DG(16:0/26:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(10Z)-heptacos-10-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
YMDB12336 | CDP-DG(16:0/27:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(heptacosanoyloxy)-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H103N3O15P2 1108.383 | |
YMDB12337 | CDP-DG(16:0/27:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(11Z)-heptacos-11-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
YMDB12338 | CDP-DG(16:0/27:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-heptacos-9-enoyloxy]-3-(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C55H101N3O15P2 1106.367 | |
YMDB12339 | CDP-DG(16:0/28:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(octacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H105N3O15P2 1122.41 | |
YMDB12340 | CDP-DG(16:0/28:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(12Z)-octacos-12-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H103N3O15P2 1120.394 | |
YMDB12341 | CDP-DG(16:0/28:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-[(10Z)-octacos-10-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H103N3O15P2 1120.394 | |
YMDB12342 | CDP-DG(16:0/29:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(nonacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C57H107N3O15P2 1136.437 | |
YMDB12343 | CDP-DG(16:0/30:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(hexadecanoyloxy)-2-(triacontanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H109N3O15P2 1150.464 | |
YMDB12344 | CDP-DG(16:1(11Z)/16:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2,3-bis[(11Z)-hexadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C44H77N3O15P2 950.054 | |
YMDB12345 | CDP-DG(16:1(11Z)/16:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-[(9Z)-hexadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C44H77N3O15P2 950.054 | |
YMDB12346 | CDP-DG(16:1(11Z)/18:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-(octadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C46H83N3O15P2 980.124 | |
YMDB12347 | CDP-DG(16:1(11Z)/18:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-[(11Z)-octadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C46H81N3O15P2 978.108 | |
YMDB12348 | CDP-DG(16:1(11Z)/18:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-[(9Z)-octadec-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C46H81N3O15P2 978.108 | |
YMDB12349 | CDP-DG(16:1(11Z)/20:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C48H87N3O15P2 1008.178 | |
YMDB12350 | CDP-DG(16:1(11Z)/20:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-[(11Z)-icos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C48H85N3O15P2 1006.162 | |
YMDB12351 | CDP-DG(16:1(11Z)/20:1(13Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-[(13Z)-icos-13-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C48H85N3O15P2 1006.162 | |
YMDB12352 | CDP-DG(16:1(11Z)/22:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-(docosanoyloxy)-3-[(11Z)-hexadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C50H91N3O15P2 1036.232 | |
YMDB12353 | CDP-DG(16:1(11Z)/22:1(13Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-[(11Z)-hexadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C50H89N3O15P2 1034.216 | |
YMDB12354 | CDP-DG(16:1(11Z)/22:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2-[(9Z)-docos-9-enoyloxy]-3-[(11Z)-hexadec-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C50H89N3O15P2 1034.216 | |
YMDB12355 | CDP-DG(16:1(11Z)/23:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-[(11Z)-tricos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C51H91N3O15P2 1048.243 | |
YMDB12356 | CDP-DG(16:1(11Z)/23:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-[(9Z)-tricos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C51H91N3O15P2 1048.243 | |
YMDB12357 | CDP-DG(16:1(11Z)/24:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(11Z)-hexadec-11-enoyloxy]-2-(tetracosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C52H95N3O15P2 1064.286 |